FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nesiritide Powder (NATRECOR) for Injection
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Janssen Pharmaceuticals (New 02/05/2018)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
1.5 mg (NDC 65847-205-25) 02/05/2018 Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English